https://novapharmanews.com/us/news/daraxonrasib-pancreatic-cancer-survival-2026 2026-06-05T21:38:27.134Z NovaPharmaNews en 2026-06-05T21:00:09.209Z Daraxonrasib Doubles Survival in Pancreatic Cancer: What Pharma Teams Need to Know daraxonrasib, pancreatic cancer https://novapharmanews.com/uploads/articles/daraxonrasib-pancreatic-cancer-survival-2026.webp Daraxonrasib Doubles Survival in Pancreatic Cancer: What Pharma Teams Need to Know https://novapharmanews.com/us/news/fda-approves-ensitrelvir-xocova-first-oral-covid-19-post-exposure-prophylaxis 2026-06-05T21:38:22.244Z NovaPharmaNews en 2026-06-05T20:52:20.223Z FDA Approves Ensitrelvir (XOCOVA) as First Oral Option for COVID-19 Post-Exposure Prophylaxis ensitrelvir, XOCOVA, COVID-19 https://novapharmanews.com/uploads/articles/fda-approves-ensitrelvir-xocova-first-oral-covid-19-post-exposure-prophylaxis.webp FDA Approves Ensitrelvir (XOCOVA) as First Oral Option for COVID-19 Post-Exposure Prophylaxis https://novapharmanews.com/us/news/generic-drugmakers-skinny-label-victory-hikma-amarin 2026-06-05T19:35:31.146Z NovaPharmaNews en 2026-06-05T17:52:04.300Z Generic Drugmakers Gain Key Victory in ‘Skinny Label’ Patent Case https://novapharmanews.com/uploads/articles/generic-drugmakers-skinny-label-victory-hikma-amarin.webp Generic Drugmakers Gain Key Victory in ‘Skinny Label’ Patent Case https://novapharmanews.com/us/news/texas-ag-investigating-energy-drinks-pharma-implications 2026-06-05T18:22:14.318Z NovaPharmaNews en 2026-06-05T15:29:30.329Z Texas AG Investigating Energy Drinks: What Pharma Teams Need to Know https://novapharmanews.com/uploads/articles/texas-ag-investigating-energy-drinks-pharma-implications.webp Texas AG Investigating Energy Drinks: What Pharma Teams Need to Know https://novapharmanews.com/eu/news/myasthenia-gravis-clinical-trial-pipeline-expands-25-companies-delveinsight 2026-06-05T10:49:48.305Z NovaPharmaNews en 2026-06-05T03:14:34.382Z Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight — regulatory updates myasthenia gravis https://novapharmanews.com/uploads/articles/myasthenia-gravis-clinical-trial-pipeline-expands-25-companies-delveinsight.webp Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight — regulatory updates https://novapharmanews.com/eu/news/mfn-drug-pricing-reshapes-international-life-sciences-licensing-deals 2026-06-05T18:08:00.052Z NovaPharmaNews en 2026-06-05T03:09:13.231Z MFN Drug Pricing Reshapes International Life Sciences Licensing Deals https://novapharmanews.com/uploads/articles/mfn-drug-pricing-reshapes-international-life-sciences-licensing-deals.webp MFN Drug Pricing Reshapes International Life Sciences Licensing Deals https://novapharmanews.com/eu/news/india-oman-cepa-fast-tracks-drug-approvals-cuts-export-barriers 2026-06-05T19:28:00.228Z NovaPharmaNews en 2026-06-05T02:54:41.963Z India-Oman CEPA Fast-Tracks Drug Approvals, Cuts Export Barriers for Pharma https://novapharmanews.com/uploads/articles/india-oman-cepa-fast-tracks-drug-approvals-cuts-export-barriers.webp India-Oman CEPA Fast-Tracks Drug Approvals, Cuts Export Barriers for Pharma https://novapharmanews.com/us/news/fda-approves-companion-diagnostic-inavolisib-hr-her2-pik3ca-mutated-breast-cancer 2026-06-05T17:18:36.268Z NovaPharmaNews en 2026-06-05T02:32:18.666Z FDA Approves Companion Diagnostic for Inavolisib in HR+/HER2–, PIK3CA-Mutated Breast Cancer inavolisib, palbociclib, fulvestrant, FoundationOne CDx, FoundationOne Liquid CDx, oncology, breast cancer, HR+/HER2–, PIK3CA-mutated breast cancer, endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative, advanced breast cancer https://novapharmanews.com/uploads/articles/fda-approves-companion-diagnostic-inavolisib-hr-her2-pik3ca-mutated-breast-cancer.webp FDA Approves Companion Diagnostic for Inavolisib in HR+/HER2–, PIK3CA-Mutated Breast Cancer https://novapharmanews.com/us/news/peptide-reclassification-rfk-jr-fda-announcement-pharmacist-take 2026-06-05T17:18:42.679Z NovaPharmaNews en 2026-06-05T01:39:48.737Z The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means — drug approvals https://novapharmanews.com/uploads/articles/peptide-reclassification-rfk-jr-fda-announcement-pharmacist-take.webp The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means — drug approvals https://novapharmanews.com/apac/news/vietnam-india-middle-power-diplomacy-pharma-market-analysis 2026-06-05T20:19:36.504Z NovaPharmaNews en 2026-06-05T00:37:08.409Z Vietnam and India Reshape Middle Power Diplomacy: Market Analysis for Pharma https://novapharmanews.com/uploads/articles/vietnam-india-middle-power-diplomacy-pharma-market-analysis.webp Vietnam and India Reshape Middle Power Diplomacy: Market Analysis for Pharma https://novapharmanews.com/us/news/scientists-uncover-new-hiding-spot-hiv-bone-marrow 2026-06-05T10:53:10.947Z NovaPharmaNews en 2026-06-05T00:23:35.461Z Scientists uncover a new hiding spot for HIV in bone marrow: Implications for cure research HIV https://novapharmanews.com/uploads/articles/scientists-uncover-new-hiding-spot-hiv-bone-marrow.webp Scientists uncover a new hiding spot for HIV in bone marrow: Implications for cure research https://novapharmanews.com/us/news/trump-administration-strips-job-protections-nih-officials-pharma-impact 2026-06-05T18:04:15.267Z NovaPharmaNews en 2026-06-04T07:08:57.385Z Trump Administration Strips Job Protections of Top NIH Officials: What Pharma Teams Must Know https://novapharmanews.com/uploads/articles/trump-administration-strips-job-protections-nih-officials-pharma-impact.webp Trump Administration Strips Job Protections of Top NIH Officials: What Pharma Teams Must Know https://novapharmanews.com/apac/news/nmpa-drug-approvals-2025-record-first-global-approvals 2026-06-05T19:30:33.116Z NovaPharmaNews en 2026-06-04T03:21:58.215Z NMPA Drug Approvals Surge in 2025: Record 61 First Global Approvals Signal Accelerated Market Access https://novapharmanews.com/uploads/articles/nmpa-drug-approvals-2025-record-first-global-approvals.webp NMPA Drug Approvals Surge in 2025: Record 61 First Global Approvals Signal Accelerated Market Access https://novapharmanews.com/eu/news/ema-ama-african-regulators-ebola-clinical-trials-2026 2026-06-05T21:36:51.784Z NovaPharmaNews en 2026-06-04T03:00:14.543Z EMA, AMA and African Regulators Unite to Accelerate Ebola Clinical Trials Ebola https://novapharmanews.com/uploads/articles/ema-ama-african-regulators-ebola-clinical-trials-2026.webp EMA, AMA and African Regulators Unite to Accelerate Ebola Clinical Trials https://novapharmanews.com/eu/news/esmo-asia-nadia-harbeck-oncology-advances 2026-06-05T18:55:12.305Z NovaPharmaNews en 2026-06-04T02:48:21.704Z Insights from ESMO Asia: Nadia Harbeck on Oncology Advances oncology https://novapharmanews.com/uploads/articles/esmo-asia-nadia-harbeck-oncology-advances.webp Insights from ESMO Asia: Nadia Harbeck on Oncology Advances https://novapharmanews.com/apac/news/cell-gene-therapy-approvals-china-regulatory-updates 2026-06-05T21:06:46.402Z NovaPharmaNews en 2026-06-04T02:48:21.704Z Cell and Gene Therapy Approvals in China: Latest Regulatory Updates gene therapy https://novapharmanews.com/uploads/articles/cell-gene-therapy-approvals-china-regulatory-updates.webp Cell and Gene Therapy Approvals in China: Latest Regulatory Updates https://novapharmanews.com/eu/news/owkin-astrazeneca-ai-collaboration-drug-research 2026-06-05T17:25:55.427Z NovaPharmaNews en 2026-06-04T02:48:21.704Z Owkin and AstraZeneca Enhance AI Collaboration for Drug Research https://novapharmanews.com/uploads/articles/owkin-astrazeneca-ai-collaboration-drug-research.webp Owkin and AstraZeneca Enhance AI Collaboration for Drug Research https://novapharmanews.com/eu/news/eu-commission-advances-critical-medicines-act 2026-06-04T12:38:13.357Z NovaPharmaNews en 2026-06-04T02:48:21.704Z EU Commission Advances Critical Medicines Act: Market Implications https://novapharmanews.com/uploads/articles/eu-commission-advances-critical-medicines-act.webp EU Commission Advances Critical Medicines Act: Market Implications https://novapharmanews.com/us/news/astrazeneca-daiichi-drug-approval-breast-cancer 2026-06-05T21:11:40.406Z NovaPharmaNews en 2026-06-04T02:48:21.704Z AstraZeneca and Daiichi's Datroway (Dato-DXd) Approved for Triple-Negative Breast Cancer: Implications for Pharma breast cancer, triple-negative breast cancer https://novapharmanews.com/uploads/articles/astrazeneca-daiichi-drug-approval-breast-cancer.webp AstraZeneca and Daiichi's Datroway (Dato-DXd) Approved for Triple-Negative Breast Cancer: Implications for Pharma https://novapharmanews.com/eu/news/hayes-esmo-breast-cancer-award-2026 2026-06-05T21:25:03.162Z NovaPharmaNews en 2026-06-04T02:48:21.704Z Hayes Receives 2026 ESMO Breast Cancer Award: Key Insights breast cancer https://novapharmanews.com/uploads/articles/hayes-esmo-breast-cancer-award-2026.webp Hayes Receives 2026 ESMO Breast Cancer Award: Key Insights https://novapharmanews.com/us/news/fierce-biotech-week-2026-recap 2026-06-05T13:48:40.894Z NovaPharmaNews en 2026-06-04T02:48:21.704Z Fierce Biotech Week 2026: Key Insights and Highlights https://novapharmanews.com/uploads/articles/fierce-biotech-week-2026-recap.webp Fierce Biotech Week 2026: Key Insights and Highlights https://novapharmanews.com/eu/news/cancer-therapy-ost-her2-2026-ema-call 2026-06-05T14:26:21.826Z NovaPharmaNews en 2026-06-04T02:48:21.704Z Cancer Therapy OST-HER2 Faces 2026 EMA Call After Survival Data OST-HER2, cancer https://novapharmanews.com/uploads/articles/cancer-therapy-ost-her2-2026-ema-call.webp Cancer Therapy OST-HER2 Faces 2026 EMA Call After Survival Data https://novapharmanews.com/apac/news/smarter-medical-devices-ecosystem-india-regulatory-updates 2026-06-05T18:56:23.238Z NovaPharmaNews en 2026-06-04T02:48:21.704Z Building a Smarter Medical Devices Ecosystem in India: Regulatory Updates healthcare technologies, medical devices https://novapharmanews.com/uploads/articles/smarter-medical-devices-ecosystem-india-regulatory-updates.webp Building a Smarter Medical Devices Ecosystem in India: Regulatory Updates https://novapharmanews.com/apac/news/decade-ai-medical-device-regulation-2015-2025 2026-06-05T18:28:36.914Z NovaPharmaNews en 2026-06-04T02:48:21.704Z A Decade of AI Medical Device Regulation: Key Updates for Pharma https://novapharmanews.com/uploads/articles/decade-ai-medical-device-regulation-2015-2025.webp A Decade of AI Medical Device Regulation: Key Updates for Pharma https://novapharmanews.com/eu/news/chmp-may-2026-output-shift-european-drug-development 2026-06-05T13:33:56.946Z NovaPharmaNews en 2026-06-04T02:48:21.704Z CHMP May 2026 Output: A New Era in Drug Approvals https://novapharmanews.com/uploads/articles/chmp-may-2026-output-shift-european-drug-development.webp CHMP May 2026 Output: A New Era in Drug Approvals https://novapharmanews.com/us/news/pharma-in-focus-regulatory-updates 2026-06-05T19:16:08.916Z NovaPharmaNews en 2026-06-04T02:48:21.704Z Pharma in Focus: Regulatory Updates You Need to Know https://novapharmanews.com/uploads/articles/pharma-in-focus-regulatory-updates.webp Pharma in Focus: Regulatory Updates You Need to Know https://novapharmanews.com/eu/news/who-europe-access-novel-medicines 2026-06-05T18:25:29.684Z NovaPharmaNews en 2026-06-04T02:48:21.704Z WHO/Europe Initiative on Access to Novel Medicines: Market Implications for Pharma https://novapharmanews.com/uploads/articles/who-europe-access-novel-medicines.webp WHO/Europe Initiative on Access to Novel Medicines: Market Implications for Pharma https://novapharmanews.com/us/news/fda-flashback-breast-cancer-april-2026 2026-06-05T16:04:17.046Z NovaPharmaNews en 2026-06-04T02:48:21.704Z FDA Flashback: Key Breast Cancer Decisions from April 2026 breast cancer https://novapharmanews.com/uploads/articles/fda-flashback-breast-cancer-april-2026.webp FDA Flashback: Key Breast Cancer Decisions from April 2026 https://novapharmanews.com/eu/news/chmp-negative-stance-acadia-rett-syndrome-drug 2026-06-05T08:49:38.997Z NovaPharmaNews en 2026-06-04T02:48:21.704Z CHMP Negative Opinion on Acadia's Rett Syndrome Drug: Implications for Investors and Pharma Teams Rett syndrome https://novapharmanews.com/uploads/articles/chmp-negative-stance-acadia-rett-syndrome-drug.webp CHMP Negative Opinion on Acadia's Rett Syndrome Drug: Implications for Investors and Pharma Teams https://novapharmanews.com/us/news/fda-approves-first-oral-covid-19-pep-drug-xocova 2026-06-05T10:56:22.301Z NovaPharmaNews en 2026-06-04T01:54:35.580Z FDA Approves First Oral COVID-19 PEP Drug, Xocova XOCOVA, ensitrelvir, Veklury, remdesivir, COVID-19 https://novapharmanews.com/uploads/articles/fda-approves-first-oral-covid-19-pep-drug-xocova.webp FDA Approves First Oral COVID-19 PEP Drug, Xocova https://novapharmanews.com/us/news/legend-biotech-in-vivo-car-t-lymphoma-data-surge 2026-06-05T16:07:05.147Z NovaPharmaNews en 2026-06-04T01:03:07.735Z Legend Biotech surges on early in vivo CAR-T data for lymphoma Kymriah, in vivo CAR-T, cell therapy, lymphoma, blood cancer https://novapharmanews.com/uploads/articles/legend-biotech-in-vivo-car-t-lymphoma-data-surge.webp Legend Biotech surges on early in vivo CAR-T data for lymphoma https://novapharmanews.com/us/news/halomd-lawsuit-update-highmark-health-no-surprises-act 2026-06-05T21:11:08.378Z NovaPharmaNews en 2026-06-03T23:40:28.314Z HaloMD Lawsuit Update: Highmark Health Alleges 'Sham Letter' and Misleading Data in No Surprises Act Dispute https://novapharmanews.com/uploads/articles/halomd-lawsuit-update-highmark-health-no-surprises-act.webp HaloMD Lawsuit Update: Highmark Health Alleges 'Sham Letter' and Misleading Data in No Surprises Act Dispute